Medicaid bans coverage for gender-affirming care for minors
醫療補助計畫禁止為未成年人提供性別肯定護理服務
更新於: 2026年8月13日 上午02:35
As of August 2026, the U.S. healthcare landscape faces a major shift regarding transgender youth.
截至2026年8月，美國的醫療保健環境正面臨針對跨性別青少年的重大轉變。
The Trump administration has announced a federal rule through the Centers for Medicare & Medicaid Services (CMS) that bans the use of Medicaid and CHIP funds for gender-affirming care for minors.
川普政府透過醫療保險和醫療補助服務中心（CMS）宣布了一項聯邦規定，禁止將醫療補助（Medicaid）與兒童健康保險計畫（CHIP）的資金用於未成年人的性別肯認照護（Gender-affirming care）。
This mandate, taking effect October 13, 2026, prohibits coverage for surgeries and hormone treatments, including puberty blockers.
這項將於2026年10月13日生效的強制規定，禁止涵蓋手術與荷爾蒙治療，包含青春期阻斷劑。
Mehmet Oz justified the policy by labeling these medical procedures as potentially harmful to children.
反之，美國兒科學會等主要醫學團體堅持此類照護在醫學上是必要的，而美國公民自由聯盟（ACLU）等組織已承諾將在法庭上挑戰該規定。
Conversely, leading medical groups like the American Academy of Pediatrics maintain that such care is medically necessary, and organizations like the ACLU have promised to challenge the rule in court.
這項聯邦行動使本已分裂的環境更加複雜，因為在該宣布之前，至少已有27個州實施了各自的禁令。
This federal action complicates an already divided landscape, as at least 27 states had already implemented their own bans prior to this announcement.
由於醫療補助是一項聯邦與州共同管理的計畫，這些服務的未來仍不明朗，且在先前提供保護性獲取管道的州可能會出現潛在衝突。
As Medicaid is a joint federal-state program, the future of these services remains uncertain, with potential conflicts emerging in states that previously offered protective access.
該政策標誌著圍繞美國性別肯認照護之法律與倫理爭議的顯著升級。
The policy marks a significant escalation in the ongoing legal and ethical debates surrounding gender-affirming care in the United States.
